Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atopic dermatitis
Pharma
Nektar extends cash runway with $90M manufacturing plant sale
Nektar is selling its Alabama manufacturing plant and reagent supply business to private equity firm Ampersand for a total value of $90 million.
Fraiser Kansteiner
Nov 4, 2024 1:16pm
J&J's Tremya, Lilly's Ebglyss score in new patient groups
Oct 25, 2024 11:00am
Incyte picks Dr. Pimple Popper to expand Opzelura campaign
Oct 14, 2024 10:23am
Organon pays up to $1.2B to acquire Dermavant and its drug Vtama
Sep 18, 2024 10:09am
Lilly secures FDA nod for atopic dermatitis therapy Ebglyss
Sep 16, 2024 11:16am
Almirall focuses on mental burden of skin disease for eczema day
Sep 16, 2024 11:02am
